Sveriges mest populära poddar
Plenary Session
Hälsa och motionMedicin

4.05 Exodus from Academia and the Regretful FDA Approval of Aducanumab with Dr. Ameet Sarpatwari

53 min•7 juli 2021
Today we are joined by Dr. Ameet Sarpatwari of Harvard Medical School to discuss how so many great minds in oncology are leaving cancer research in academia for industry. We also talk about the evidence (or lack thereof) behind the recent FDA approval of aducanumab to treat Alzheimer's disease. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

Fler avsnitt av Plenary Session

Visa alla avsnitt av Plenary Session
Longevity Episode 2 - Nutrition science
•37 min
Longevity Lecture series Introduction and Lecture 1
•29 min
CABINET - trial - Cabozantinib for NET
•19 min
CIA says lab leak, Fauci's pardon, NIH's meetings, RFK Jr's hearing & more!
•39 min
Why the NIH is a broken funding system
•32 min
Elon's 6 Engineers/ Unelected/ RFK Jr/ MMR vaccines/ DEI/ USAID and NIH funding complaints
•23 min
Trump is breaking media brains / NIH cuts indirect payments and scientists freak out
•27 min
RFK Jr takes office/ CDC layoffs/ Varmus criticizes Jay's proposal for Academic Freedom
•28 min
Trump's Big Health Care Changes: NIH study sections, MMWR gag order, WHO withdrawal & more!
•29 min
The ENTIRE healthcare system is broken, not just health insurance companies
•19 min

Plenary Session med Vinay Prasad, MD MPH finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.